Metal oxide nanoparticles interact with immune cells and activate different cellular responses

Area of Science:

• Nanotechnology
• Immunology
• Toxicology

Background:

• Nanoparticles (Nps) can elicit cellular responses beyond cell death, including inflammation.
• Understanding the immunomodulatory effects of metal oxide nanoparticles (moNps) on human immune cells is crucial for risk assessment.

Purpose of the Study:

• To characterize the immune response of human lymphoid cells exposed to four different moNps: cerium dioxide (CeO2), titanium dioxide (TiO2), aluminum oxide (Al2O3), and zinc oxide (ZnO).
• To investigate the activation of key signaling pathways, including mitogen-activated protein kinase (MAPK) subfamilies and nuclear factor kappa-light-chain-enhancer of activated B-cells inhibitor (IκBα).
• To assess alterations in gene expression within immune cells upon incubation with these moNps.

Main Methods:

• Incubation of human lymphoid cells with four types of moNps (CeO2, TiO2, Al2O3, ZnO) at varying concentrations.
• Analysis of MAPK signaling pathways and IκBα protein levels.
• Quantitative assessment of gene expression changes in response to moNp exposure.

Main Results:

• All tested moNps activated distinct signaling pathways and modulated gene expression in human lymphocytes.
• ZnO nanoparticles exhibited the highest level of activity, with released Zn2+ ions identified as the primary mechanism of toxicity.
• CeO2 nanoparticles induced the least significant changes in gene expression and IκBα protein levels.
• The observed effects were significantly influenced by the type and concentration of moNps, as well as the pre-exposure activation status of the cells.

Conclusions:

• Metal oxide nanoparticles differentially modulate immune cell signaling and gene expression.
• The toxicity and immunomodulatory potential of moNps are particle-specific and concentration-dependent.
• Cellular activation status plays a critical role in determining the response to nanoparticle exposure.